301 results on '"Wishart, Thomas M."'
Search Results
2. Assessment of the alpha 7 nicotinic acetylcholine receptor as an imaging marker of cardiac repair-associated processes using NS14490
3. Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures
4. Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex
5. Training associated alterations in equine respiratory immunity using a multiomics comparative approach
6. ATP-binding cassette family C member 1 constrains metabolic responses to high-fat diet in male mice.
7. Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo.
8. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease
9. Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses
10. Hyaluronan in mesenchymal stromal cell lineage differentiation from human pluripotent stem cells: Application in serum free culture
11. Application across species of a one health approach to liquid sample handling for respiratory based -omics analysis
12. Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep
13. Collateral Sprouting of Peripheral Sensory Neurons Exhibits a Unique Transcriptomic Profile
14. Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.
15. Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease
16. Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype
17. Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation
18. Commonality amid diversity: Multi-study proteomic identification of conserved disease mechanisms in spinal muscular atrophy
19. Analysis of gene expression in the nervous system identifies key genes and novel candidates for health and disease
20. An Optimized Comparative Proteomic Approach as a Tool in Neurodegenerative Disease Research
21. Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment
22. The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap
23. The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo
24. Author Reply to Peer Reviews of Necroptosis inhibition counteracts axonal degeneration, cognitive decline and key hallmarks of aging, promoting brain rejuvenation
25. Synaptic proteomics reveal distinct molecular signatures of cognitive change andC9ORF72repeat expansion in the human ALS cortex
26. The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap
27. Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures
28. Efficacy of recombinant human PPT1 enzyme replacement therapy in mouse and sheep models of CLN1 disease
29. Additional file 5 of Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex
30. Additional file 2 of Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex
31. Temporal Profiling of the Cortical Synaptic Mitochondrial Proteome Identifies Ageing Associated Regulators of Stability
32. Necroptosis inhibition counteracts neurodegeneration, memory decline and key hallmarks of aging, promoting brain rejuvenation
33. Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy
34. Quantitative imaging of tissue sections using infrared scanning technology
35. Confocal Endomicroscopy of Neuromuscular Junctions Stained with Physiologically Inert Protein Fragments of Tetanus Toxin
36. Training Associated Alterations in Equine Respiratory Immunity Using a Multiomics Comparative Approach
37. Training-Associated Alterations In Equine Respiratory Immunity – A Multi-Omics Comparative Approach.
38. Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target
39. A One Health Approach to Simple Liquid Sample Handling for Respiratory Based -Omics Analysis; Tracheal Wash and Bronchoalveolar Lavage Fluid
40. Cellular and Molecular Anatomy of the Human Neuromuscular Junction
41. Microarray profiling emphasizes transcriptomic differences between hippocampal in vivo tissue and in vitro cultures
42. Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality?
43. Reversible molecular pathology of skeletal muscle in spinal muscular atrophy
44. ApoE isoform-specific regulation of regeneration in the peripheral nervous system
45. Pre-natal manifestation of systemic developmental abnormalities in spinal muscular atrophy
46. Comparative anatomy of the mammalian neuromuscular junction
47. A mouse model for spinal muscular atrophy provides insights into non-alcoholic fatty liver disease pathogenesis
48. Neuromuscular junctions are stable in patients with cancer cachexia
49. SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy
50. Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.